Robeco Institutional Asset Management B.V. Grows Position in STERIS plc $STE

Key Points

• Robeco Institutional Asset Management boosted its stake in STERIS by 393.2% in Q4 and now holds 28,816 shares worth about $7.31 million, while institutional investors collectively own 94.69% of the company.
• Director Cynthia L. Feldmann sold 3,098 shares on March 5 at an average price of $237.21—an 81.46% reduction in her holdings—leaving insiders with just 1.07% ownership.
• STERIS reported Q results with EPS of $2.53 (in line with estimates), set FY2026 guidance of 10.15–10.30 EPS, and pays a quarterly dividend of $0.63 (annualized yield ~1.1%).

Robeco Institutional Asset Management B.V. raised its position in shares of STERIS plc (NYSE:STE - Free Report) by 393.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,816 shares of the medical equipment provider's stock after buying an additional 22,973 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in STERIS were worth $7,305,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in STERIS by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 12,213,521 shares of the medical equipment provider's stock valued at $3,022,114,000 after buying an additional 50,393 shares in the last quarter. State Street Corp grew its holdings in STERIS by 4.0% during the 3rd quarter. State Street Corp now owns 4,354,839 shares of the medical equipment provider's stock valued at $1,077,564,000 after buying an additional 166,736 shares in the last quarter. Orbis Allan Gray Ltd grew its holdings in STERIS by 36.0% during the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider's stock valued at $504,486,000 after buying an additional 556,088 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in STERIS by 16.4% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider's stock valued at $387,797,000 after buying an additional 221,199 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in STERIS by 4.9% during the 3rd quarter. Invesco Ltd. now owns 1,280,142 shares of the medical equipment provider's stock valued at $316,758,000 after buying an additional 59,443 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

Insider Activity

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the firm's stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the completion of the sale, the director directly owned 705 shares of the company's stock, valued at approximately $167,233.05. This trade represents a 81.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.07% of the company's stock.

STERIS Price Performance

Shares of STERIS stock opened at $221.64 on Thursday. The stock has a market cap of $21.74 billion, a price-to-earnings ratio of 30.91 and a beta of 1.07. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The stock has a 50 day moving average price of $232.06 and a 200-day moving average price of $246.31. STERIS plc has a one year low of $209.98 and a one year high of $269.44.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting analysts' consensus estimates of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.The company's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business posted $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were paid a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Tuesday, February 17th. STERIS's dividend payout ratio (DPR) is currently 35.15%.

Wall Street Analyst Weigh In

STE has been the subject of several analyst reports. Wall Street Zen lowered STERIS from a "strong-buy" rating to a "buy" rating in a research note on Saturday, March 28th. Weiss Ratings reiterated a "buy (b)" rating on shares of STERIS in a report on Friday, January 9th. Six research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $275.20.

STERIS Profile

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.